Top Markets
Coin of the day
Oxurion N.V. Oxurion N.V.

Oxurion N.V.

OXUR
Rangering i aksjer #39567
Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a... Headquartered in Leuven, Belgium, and established in 1991, Oxurion N.V. is a biopharmaceutical firm focused on researching, developing, and bringing to market treatments for various ocular conditions worldwide. Its primary commercialized offering is JETREA, a medication used to address vitreomacular adhesion and vitreomacular traction. The company's development pipeline includes THR-149, a plasma kallikrein inhibitor currently undergoing Phase II clinical trials for diabetic macular edema (DME), and THR-687, an integrin antagonist also in Phase II trials for DME. Oxurion has forged strategic partnerships with Bicycle Therapeutics, INC Research, and Galapagos NV. The organization was formerly known as ThromboGenics NV before officially changing its name to Oxurion NV in September 2018.
Aksjekurs
$0.003084
Markedsverdi
$434.03K
Endring (1 dag)
-7.14%
Endring (1 år)
-89.24%
Land
BE
Handel Oxurion N.V. (OXUR)

Kategori

Pris OXUR pris med markedsverdi på B
Oxurion N.V. Oxurion N.V.
OXUR
$0.003084
Markedsverdi av Oxurion N.V.(OXUR)
Markedsverdi: $434.03K
Per August 2026 har Oxurion N.V. en markedsverdi på $434.03K. Dette gjør Oxurion N.V. til det 39567th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Oxurion N.V. fra 2006 til 2026
OXUR sammenlignet med topp 5 mest populære stocks
Pris på OXUR Eiendel B Markedsverdi for B Resultater
Oxurion N.V. Oxurion N.V.
$38,864.20 $434.03K
$5.470T +1,260,186,454.81%
Oxurion N.V. Oxurion N.V.
$31,741.10 $434.03K
$4.467T +1,029,217,230.28%
Oxurion N.V. Oxurion N.V.
$29,661.40 $434.03K
$4.174T +961,782,373.59%
Oxurion N.V. Oxurion N.V.
$26,291.17 $434.03K
$3.700T +852,501,128.88%
Oxurion N.V. Oxurion N.V.
$20,281.74 $434.03K
$2.854T +657,643,093.76%